You will find in this section the latest medical thoughts expressed by the experts themselves which we feel are of national importance to all folks.
Examples to guide the wording for PPI statements Data sharing We require a data sharing statement for all research papers. For papers that do not report a trial, we do not require that the authors agree to share the data, just that they say whether they will.
For reports of clinical trials, we ask that the authors commit to making the relevant anonymised patient level data available on reasonable request see editorial.
This policy applies to any research article that reports the main endpoints of a randomised controlled trial of one or more drugs or medical devices in current use, whether or not the trial was funded by industry.
As for "reasonable request," The BMJ is not in a position to adjudicate, but we will expect requesters to submit a protocol for their re-analysis to the authors and to commit to making their results public. We will encourage those requesting data to send a rapid response to thebmj.
If the request is refused we will ask the authors of the paper to explain why. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record. We encourage authors of all research articles in The BMJ to link their articles to the raw data from their studies.
For clinical trials, we require data sharing on request as a minimum and- if authors of such trials are willing to go further and share the data openly, so much the better.
The BMJ has partnered with the Dryad digital repository datadryad. Data requesters should do the following: Our role is limited to making the request process public, and all correspondence related to the request may be made public through rapid responses to the paper. To ensure this, we aim to appraise the ethical aspects of any submitted work that involves human participants, whatever descriptive label is given to that work including research, audit, and sometimes debate.
This policy also applies on the very rare occasions that we publish work done with animal participants.
Transparency statement Please include in your manuscript a transparency declaration: The BMJ is committed to making the editorial process transparent and ethical. Role of the funding source Please include in the manuscript a statement giving the details of all sources of funding for the study.
As appropriate, the statement must include a description of the role of the study sponsor s or funder sif any, in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.
In addition, the statement must confirm the independence of researchers from funders and that all authors, external and internal, had full access to all of the data including statistical reports and tables in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis is also required.
If you are submitting an original article reporting an industry sponsored clinical trial, postmarketing study, or other observational study please follow the guidelines on good publication practice GPP2 and on properly reporting the role of professional medical writers. The BMJ will not consider for publication any study that is partly or wholly funded by the tobacco industry, as explained in this editorial.
Patient and Public Involvement statement Within the Methods section of your paper, please state if and how patients and the public were involved in the research you are describing.
For more information, please see the specific guidance on mandatory reporting of patient and public involvement above.
If patients and the public were not involved this information should be formally documented in the Patient and Public Involvement statement. Summary boxes Please produce a box offering a thumbnail sketch of what your article adds to the literature.
The box should be divided into two short sections, each with short sentences. What is already known on this topic In two or three single sentence bullet points, please summarise the state of scientific knowledge on this topicbefore you did your study, and why this study needed to be done.
Be clear and specific, not vague. For example, your study might have asked and answered a new question one whose relevance has only recently become clear ; contradicted a belief, dogma, or previous evidence provided a new perspective on something that is already known in general; or provided evidence of higher methodological quality for a message that is already known.
DO not make statements that are not directly supported by your data. This policy on prospective registration applies to trials that started after 1 July ; for older trials retrospective registration will be acceptable, but only if completed before submission of the manuscript to the journal.
The trial registration number and name of register should be included as the last line of the structured abstract. In your submission, please include details about registration: The BMJ relies on information contained in trial registries.
If authors believe that information in the registry is incorrect they should make their case to registry officials.
Eligible trials have been defined by ICMJE since 1 July as trials "where human participants are prospectively assigned to one or more health-related interventions including health services and behavioural interventions to evaluate the effects on health outcomes," and before that were defined more narrowly as trials "where human participants are prospectively assigned to investigate the cause and effect relationship between a medical intervention and health outcome.COPE Best Practice Guidelines for Journal Editors • adopt peer-review methods best suited for their journal and the research community it serves.
Objective. To report the results of a systematic literature review concerning the security and privacy of electronic health record (EHR) systems. Overview. The Journal of Applied Laboratory Medicine (JALM), issued bi-monthly, is published online by the American Association for Clinical regardbouddhiste.com journal welcomes contributions that showcase research on clinically relevant laboratory topics as well as those that provide commentary on the practice of laboratory medicine.
Edema is defined as a palpable swelling caused by an increase in interstitial fluid volume. The most likely cause of leg edema in patients over age 50 is venous insufficiency. Objective. To describe and discuss the process used to write a narrative review of the literature for publication in a peer-reviewed journal.
Publication of narrative overviews of the literature should be standardized to increase their objectivity. Is The BMJ the right journal for my article?
Which research does The BMJ prioritise? Advice on OA and peer review, writing, laying out, and submitting articles.